De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Bristol-Myers Squibb Dividend
Dividend criteriumcontroles 5/6
Bristol-Myers Squibb is een dividendbetalend bedrijf met een huidig rendement van 4.57%. Volgende betalingsdatum is op 1st November, 2024 met een ex-dividenddatum van 4th October, 2024.
Belangrijke informatie
4.6%
Dividendrendement
-74%
Uitbetalingsratio
Gemiddelde opbrengst industrie | 2.2% |
Volgende betaaldatum dividend | 01 Nov 24 |
Ex-dividenddatum | 04 Oct 24 |
Dividend per aandeel | US$2.400 |
Winst per aandeel | -US$3.23 |
Dividendrendementsvoorspelling | 4.9% |
Recente dividendupdates
Bristol-Myers Squibb (NYSE:BMY) Is Due To Pay A Dividend Of $0.60
Mar 21Bristol-Myers Squibb (NYSE:BMY) Is Due To Pay A Dividend Of $0.60
Mar 07Recent updates
Bristol-Myers Squibb: A High-Yield Bargain With Growth On The Horizon
Oct 06Bristol-Myers Squibb: Cobenfy Approval A Major Coup For The Dealmaker (Upgrade)
Sep 27Bristol-Myers Still A Value Play Despite Appreciating 26.56% From 2024 Lows
Sep 06Bristol-Myers Squibb Company's (NYSE:BMY) Share Price Is Matching Sentiment Around Its Revenues
Aug 15Bristol-Myers Squibb: A Potential Comeback In Healthcare
Aug 06Bristol-Myers Squibb: Q2 Earnings Look Like An Inflection Point
Jul 27Bristol Myers Squibb: The More It Drops, The More I Buy
Jul 16Is Bristol-Myers Squibb (NYSE:BMY) A Risky Investment?
Jun 13Bristol Myers: Quality Fundamentals Suppressed By Interest Rates
Jun 09Bristol-Myers Squibb: Looking Beyond The One-Time Quarterly Loss
Jun 03Bristol-Myers Squibb: 5.5% Yielder Has Been Crushed In What Could Be A Generational Buying Opportunity
May 23Bristol-Myers Squibb: A Lost Decade?
May 03Lacklustre Performance Is Driving Bristol-Myers Squibb Company's (NYSE:BMY) Low P/S
Apr 29Is Bristol Myers Squibb A Buy At These Bottom Levels?
Apr 22Bristol Myers Squibb: Seriously Undervalued At Peak Pessimism (Rating Upgrade)
Apr 12Bristol-Myers Squibb Is A Speculative Buy On Price Action (Technical Analysis)
Apr 02Bristol-Myers Squibb (NYSE:BMY) Is Due To Pay A Dividend Of $0.60
Mar 21Bristol-Myers Squibb Is Not A Buy For Me
Mar 19Bristol-Myers Squibb: Compelling Value From The New Products Portfolio And 4.5% Yield
Mar 07Bristol-Myers Squibb (NYSE:BMY) Is Due To Pay A Dividend Of $0.60
Mar 07We Think Bristol-Myers Squibb's (NYSE:BMY) Healthy Earnings Might Be Conservative
Feb 20Bristol-Myers Squibb Company (NYSE:BMY) Just Released Its Annual Results And Analysts Are Updating Their Estimates
Feb 06Bristol-Myers Squibb: Massive Discount Spells Opportunity
Feb 04Stabiliteit en groei van betalingen
Dividenden ophalen
Stabiel dividend: Het dividend per aandeel van BMY is de afgelopen 10 jaar stabiel gebleven.
Groeiend dividend: De dividendbetalingen van BMY zijn de afgelopen 10 jaar gestegen.
Dividendrendement versus markt
Bristol-Myers Squibb Dividendrendement versus markt |
---|
Segment | Dividendrendement |
---|---|
Bedrijf (BMY) | 4.6% |
Markt onderkant 25% (US) | 1.4% |
Markt Top 25% (US) | 4.4% |
Gemiddelde industrie (Pharmaceuticals) | 2.2% |
Analist prognose (BMY) (tot 3 jaar) | 4.9% |
Opmerkelijk dividend: Het dividend van BMY ( 4.54% ) is hoger dan dat van de onderste 25% van de dividendbetalers op de US markt ( 1.43% ).
Hoog dividend: Het dividend van BMY ( 4.54% ) behoort tot de top 25% van dividendbetalers in de US markt ( 4.29% )
Winstuitkering aan aandeelhouders
Verdiendekking: BMY keert dividend uit, maar het bedrijf is verliesgevend.
Contante uitbetaling aan aandeelhouders
Kasstroomdekking: Met zijn redelijk lage cash payout ratio ( 37.6% ) worden de dividendbetalingen van BMY goed gedekt door de kasstromen.